Showing 8201-8210 of 19305 results for "".
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
https://reachmd.com/programs/neurofrontiers/applying-cbt-for-psychosis-in-schizophrenia-care-strategies-for-expanding-access/36647/Despite decades of evidence supporting cognitive behavioral therapy (CBT) for psychosis, most patients with schizophrenia in the U.S. never receive it due to systemic barriers like provider shortages and fragmented transitions after hospitalization. To address these gaps, Dr. David Kimhy joins Dr. CNavigating Nail Psoriasis: Treatment Strategies for Patient-Centered Care
https://reachmd.com/programs/clinicians-roundtable/navigating-nail-psoriasis-treatment-strategies-for-patient-centered-care/32867/Explore expert recommendations and long-term management strategies for nail psoriasis.Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
https://reachmd.com/programs/cme/treatment-of-oab-and-the-managed-care-professional-balancing-the-double-edged-sword/15362/Are you prepared to actively engage with your patients about their overactive bladder?Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
https://reachmd.com/programs/cme/Case-in-Point-Applying-PI3K-Combinations-in-Early-Recurrent-HR-HER2-mBC/37336/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
https://reachmd.com/programs/neurofrontiers/rozanolixizumab-for-myasthenia-gravis-an-alternative-to-corticosteroids/30069/Here’s how rozanolixizumab compares to other treatment options for myasthenia gravis.Exploring Lateral Wall Collapse and Hypoglossal Nerve Stimulation in OSA
https://reachmd.com/programs/clinicians-roundtable/exploring-lateral-wall-collapse-and-hypoglossal-nerve-stimulation-in-osa/35654/A recent study explored whether lateral wall collapse can predict hypoglossal nerve stimulation efficacy in patients with obstructive sleep apnea (OSA). Join Dr. Daniel Vena as he explains the findings from this research and areas for future explanation. Dr. Vena is an Assistant Professor of MedicinRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
https://reachmd.com/programs/dermconsult/pso-hs-subset-genetic-risk/39676/Evaluating Sabirnetug in Early Alzheimer’s: Targeting Soluble Aβ Oligomers
https://reachmd.com/programs/neurofrontiers/sabirnetug-early-alzheimers/40000/Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/balancing-efficacy-and-tolerability-in-metastatic-breast-cancer-treatment/35459/When making treatment decisions for patients with metastatic breast cancer, acknowledging both efficacy and tolerability is key. Dr. Paolo Tarantino joins the program to explain how patient-specific factors and timely treatment changes can help optimize outcomes. Dr. Tarantino is a medical oncologisReducing Food Allergy Reactions with an Asthma Treatment
https://reachmd.com/programs/frontlines-food-allergies/reducing-food-allergy-reactions-with-an-asthma-treatment/26318/